Literature DB >> 10081997

Comparison between dodecanedioic acid and long-chain triglycerides as an energy source in liquid formula diets.

G Mingrone1, A De Gaetano, A V Greco, E Capristo, G Benedetti, M Castagneto, G Gasbarrini.   

Abstract

BACKGROUND: Dicarboxylic acids (DA) are water-soluble substances with high-energy density proposed as an alternative lipid substrate for nutrition purposes. The aim of the present study was to investigate the interaction between glucose and DA or long-chain triglyceride (LCT) metabolism after oral administration.
METHODS: Two test meals containing either dodecanedioic acid (C12, the 12-atom DA) or LCT, together with glucose and amino acids, were each administered to five healthy volunteers. Tracer amounts of 14C-dodecanedioic acid were added to the C12 meal to recover expired traced CO2 and estimate the minimum rate of C12 oxidation. Glucose, insulin, and C12 plasma levels were measured for 360 minutes after the test meal. Indirect calorimetry was performed for the duration of the study.
RESULTS: LCTs proved ineffective in promoting their own oxidation after oral administration. On the contrary, C12 was promptly oxidized, a minimum of 21.9%+/-8.3% of the administered amount giving rise to the recovered expired CO2. This difference in metabolic fate was reflected in a sparing effect on glucose: suprabasal respiratory quotient and suprabasal carbohydrate oxidation were significantly (p < .05) lower under C12 administration than under LCT administration, with a difference of 0.024+/-0.015 in respiratory quotient (RQ) and a difference of 0.791+/-0.197 kJ/min in carbohydrate oxidation. In particular, carbohydrate oxidation increased by 54% over basal with LCT but only by 28% with C12 administration. RQ increased over basal by 5.8% with LCT but only by 3.0% with C12 administration.
CONCLUSIONS: These results show a fundamental metabolic difference between conventional lipids and DAs, which is the basis for a possible role of DAs in clinical nutrition. The fate of spared glucose is likely to be storage in glycogen form when dodecanedioic acid is made available as an energy source.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081997     DOI: 10.1177/014860719902300280

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  5 in total

Review 1.  Use of dicarboxylic acids in type 2 diabetes.

Authors:  Geltrude Mingrone; Lidia Castagneto-Gissey; Katherine Macé
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Role of mitochondrial acyl-CoA dehydrogenases in the metabolism of dicarboxylic fatty acids.

Authors:  Sivakama S Bharathi; Yuxun Zhang; Zhenwei Gong; Radhika Muzumdar; Eric S Goetzman
Journal:  Biochem Biophys Res Commun       Date:  2020-04-29       Impact factor: 3.575

3.  Compartmentation of Metabolism of the C12-, C9-, and C5-n-dicarboxylates in Rat Liver, Investigated by Mass Isotopomer Analysis: ANAPLEROSIS FROM DODECANEDIOATE.

Authors:  Zhicheng Jin; Fang Bian; Kristyen Tomcik; Joanne K Kelleher; Guo-Fang Zhang; Henri Brunengraber
Journal:  J Biol Chem       Date:  2015-06-12       Impact factor: 5.157

4.  Six weeks' sebacic acid supplementation improves fasting plasma glucose, HbA1c and glucose tolerance in db/db mice.

Authors:  M Membrez; C J Chou; F Raymond; R Mansourian; M Moser; I Monnard; C Ammon-Zufferey; K Mace; G Mingrone; C Binnert
Journal:  Diabetes Obes Metab       Date:  2010-12       Impact factor: 6.577

5.  Poly(glycerol-dodecanoate), a biodegradable polyester for medical devices and tissue engineering scaffolds.

Authors:  Francesco Migneco; Yen-Chih Huang; Ravi K Birla; Scott J Hollister
Journal:  Biomaterials       Date:  2009-08-27       Impact factor: 12.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.